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Expression of truncated Kir6.2 
promotes insertion of functionally 
inverted ATP‑sensitive  K+ channels
Benjamin A. Heitz1,5, Robert Bränström3,4,5*, Wei Yang1, Yiding Huang1, Tilo Moede3, 
Ingo B. Leibiger3, Barbara Leibiger3, Liu Qi Chen1, Jia Yu3, Shao‑Nian Yang3, Olof Larsson3, 
S. Scott Saavedra1,2, Per‑Olof Berggren3 & Craig A. Aspinwall1,2
ATP‑sensitive  K+  (KATP) channels couple cellular metabolism to electrical activity in many cell types. 
Wild‑type  KATP channels are comprised of four pore forming (Kir6.x) and four regulatory (sulfonylurea 
receptor, SURx) subunits that each contain RKR endoplasmic reticulum retention sequences that 
serve to properly translocate the channel to the plasma membrane. Truncated Kir6.x variants 
lacking RKR sequences facilitate plasma membrane expression of functional Kir6.x in the absence of 
SURx; however, the effects of channel truncation on plasma membrane orientation have not been 
explored. To investigate the role of truncation on plasma membrane orientation of ATP sensitive  K+ 
channels, three truncated variants of Kir6.2 were used (Kir6.2ΔC26, 6xHis‑Kir6.2ΔC26, and 6xHis‑
EGFP‑Kir6.2ΔC26). Oocyte expression of Kir6.2ΔC26 shows the presence of a population of inverted 
inserted channels in the plasma membrane, which is not present when co‑expressed with SUR1. 
Immunocytochemical staining of intact and permeabilized HEK293 cells revealed that the N‑terminus 
of 6xHis‑Kir6.2ΔC26 was accessible on both sides of the plasma membrane at roughly equivalent 
ratios, whereas the N‑terminus of 6xHis‑EGFP‑Kir6.2Δ26 was only accessible on the intracellular 
face. In HEK293 cells, whole‑cell electrophysiological recordings showed a ca. 50% reduction in  K+ 
current upon addition of ATP to the extracellular solution for 6xHis‑Kir6.2ΔC26, though sensitivity 
to extracellular ATP was not observed in 6xHis‑EGFP‑Kir6.2ΔC26. Importantly, the population of 
channels that is inverted exhibited similar function to properly inserted channels within the plasma 
membrane. Taken together, these data suggest that in the absence of SURx, inverted channels can 
be formed from truncated Kir6.x subunits that are functionally active which may provide a new model 
for testing pharmacological modulators of Kir6.x, but also indicates the need for added caution when 
using truncated Kir6.2 mutants.
Adenosine triphosphate (ATP)-sensitive  K+  (KATP) channels are present in a wide range of  tissues1–4 includ-
ing pancreatic islet  cells4–8,  heart9–11, skeletal  muscle12, vascular smooth  muscle11,13, and  brain14.  KATP chan-
nels serve to couple the metabolic state of the cell to electrical  activity6. As such,  KATP channels play key roles 
in regulating diverse biological functions such as insulin  secretion6,15, cardiac action  potentials16,17, ischemic 
 preconditioning18,19, and blood  pressure20.
KATP channel structure has been investigated in detail in a range of  tissues1,3,4,21. Cloning and reconstitution of 
functional  KATP channels and channel variants have illuminated key advances in  KATP channel structure–function 
 relationships7. Structurally,  KATP channels are heterooctamers comprised of four pore forming (Kir6.x) subunits 
from the family of small inwardly rectified  K+ channels and four regulatory subunits (SURx) from the sulfony-
lurea receptor  family1,3,4,21,22. While most physiological and pharmaceutical ligand sensitivity is imparted by the 
SURx  subunits1,3,4,23, ATP, phosphoinositides and long-chain coenzyme A (LC-CoA) esters act via the Kir6.x 
 subunit3,24–29. Among the most studied  KATP channels are those expressed in the insulin secreting pancreatic 
β-cell, where the  KATP channel is comprised of Kir6.2 and  SUR11,29–31. A range of diseases are associated with 
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either mutation and/or improper trafficking of SURx or Kir6.2 subunits, including type 2 diabetes  mellitus8,32,33, 
and persistent hyperinsulinemic hypoglycemia of infancy (PHHI)3,20,34–36.
Functional expression of wild-type Kir6.2 in the plasma membrane of model organisms requires co-expres-
sion with  SURx7,29. Detailed investigation of this phenomenon revealed the presence of an endoplasmic reticu-
lum (ER) retention signal comprised of a three amino acid (RKR) sequence on both Kir6.2 and  SURx37. Proper 
trafficking of the  KATP channel requires that all RKR sequences, from both subunits, be shielded, which occurs 
during assembly of the channel complex within the  ER37. Further, only functional  KATP channels in the proper 
stoichiometric ratio in the ER can sufficiently mask the RKR retention signal and facilitate export to the Golgi 
apparatus and eventually the plasma  membrane37.
The RKR sequence in Kir6.2 is positioned near the C-terminus (AA369-371, Fig. 1) whereas in SUR1 the 
RKR sequence is positioned near nuclear binding fold-1 (Walker A motif)36,37. Mutation of RKR to AAA in SUR1 
increases surface expression of sulfonylurea-sensitive  K+ currents whereas the RKR to AAA mutation in Kir6.2 
increases the expression of sulfonylurea-insensitive  K+ currents due to enhanced Kir6.2 cell-surface  expression37. 
Additionally, truncation of Kir6.2, where the last 26 or 36 amino acids (Kir6.2ΔC26 or Kir6.2ΔC36) containing 
the RKR signal were removed, facilitates expression of functional  K+ channel activity that retains Kir6.2 ligand 
sensitivity in the absence of  SUR126. Therefore, the truncated mutants have been used to investigate ligand bind-
ing sites and other  KATP channel structure–function  relationships26,27,38,39.
Proper assembly of the  KATP channel complex within the ER and subsequent regulated trafficking ensure 
normal orientation within the cell  membrane37. However, little is known regarding the orientation of channels 
formed from truncated Kir6.2 mutants. This is particularly important since normal orientation is required to 
maintain ionic balance within the cell. Importantly, the  KATP channel can conduct ions in both directions, yield-
ing both inward and outward currents of different  magnitudes38,40–43; however, the ligand sensitivity is specific 
to individual faces of the assembled channel. Many studies utilizing Kir6.2 mutants rely on whole-cell currents 
from mammalian cells or whole-cell or excised macropatch currents from Xenopus  oocytes26 and thus may not be 
truly indicative of the population of normally oriented channels and may contain substantial ligand-insensitive 
background current resulting from abnormally oriented channels. In this work, we have investigated the effects 
of truncation of RKR on the plasma membrane orientation of Kir6.2 mutants expressed in Xenopus oocytes and 
mammalian cells using a combination of electrophysiological and immunocytochemical techniques.
Materials and methods
HEK293 culture. Human embryonic kidney (HEK293) cells, supplied by The American Type Culture Col-
lection (ATCC), were cultured in minimum essential medium (MEM) supplemented with 10% fetal bovine 
serum (FBS) and 1% streptomycin and penicillin and incubated at 5%  CO2, 37 °C. Media were changed every 
2–3 days. Cells were split at 80–90% confluency using Puck’s EDTA (140 mM NaCl, 5.5 mM KCl, 5.5 mM glu-
cose, 4.2 mM  NaHCO3, 0.5 mM EDTA, pH 7.40), followed by trypsin–EDTA with gentle rocking, and harvested 
with MEM. Cells were then centrifuged at 200 g for 2 min, resuspended into fresh MEM and placed into new 
flask at a 1:10 dilution. All media and additives were obtained from Invitrogen.
Xenopus leavis oocytes. For collection of oocytes, large female Xenopus laevis were anaesthetized 
with 3-aminobenzoic acid methyl ester (1.5 g/L of water, Sigma) and handled using a previously established 
 protocol44. Briefly, oocytes were removed from one ovary by laparotomy, the incision was sutured, and the ani-
mal was allowed to recover. Oocytes, stage V–VI, were defolliculated using collagenase A and injected using 
an Eppendorf transjector (Eppendorf, Hamburg, Germany) with 0.5–5 ng of mRNA/50 nL of sterile RNase-
free water, encoding Kir6.2ΔC26 or Kir6.2ΔC26 together with SUR1. Oocytes were maintained in culture at a 
temperature of 19 °C, and experiments were performed 2–5 days after mRNA injection. Control oocytes were 












Figure 1.  Schematic diagram of Kir6.2 variants. Illustration shows the Kir6.2 constructs used with the N- and 
C-termini deleted and/or fused with 6xHis and EGFP. Full length wild-type Kir6.2 contains 390 amino acids 
with two transmembrane segments (M1 and M2) and a pore-forming H5 segment (i). C-terminal truncated 
Kir6.2, Kir6.2ΔC26 (ii), N-terminal 6xHis tag fused with Kir6.2ΔC26, 6xHis-Kir6.2ΔC26 (iii), and 6xHis and 
EGFP chimera N-terminal fused with Kir6.2ΔC26, 6xHis-EGFP-Kir6.2ΔC26 (iv).
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Preparation of expression plasmids for Kir6.2 mutants. For HEK293 cells, Kir6.2 mutants were 
originated from full-length human Kir6.2 cDNA template (courtesy of Dr. Joseph Bryan). The Kir6.2ΔC26 gene 
fragment was cloned into pcDNA4/HisMax-TOPO-TA vector using the TA cloning technique to construct a 
plasmid for expressing 6xHis-Kir6.2ΔC26 protein in mammalian cells. The sequences of the forward and reverse 
PCR primers were 5′-GGA TCC ATG CTG TCC CGC AAG GGC ATC-3′ and 5′-GGA TCC TCA GGC TGA 
GGC GAG GGT CAG-3′, respectively. The plasmid for expressing 6xHis-EGFP-Kir6.2ΔC26 in HEK293 cells 
was prepared by inserting the Kir6.2ΔC26 gene fragment from Kir6.2 cDNA into pET28a(+)/EGFP  plasmid45 
using forward (5′-ATA-GTC GAC AAA TGC TGT CCC GCA AGG GCA T-3′) and reverse primer (5′-ATG 
CGG CCG CAT CAG GCT GAG GCG AGG GTC AGA G-3′). After the pET28a(+)/EGFP-Kir6.2ΔC26 tem-
plate was prepared, the EGFP- Kir6.2ΔC26 sequence was amplified using forward (5′-GGA TCC ATG GTG 
AGC AAG GGC GAG GAG-3′) and reverse (5′-GGA TCC TCA GGC TGA GGC GAG GGT CAG-3′), which 
was subsequently ligated into pcDNA4/HisMax-TOPO-TA vector to form the recombinant plasmid for express-
ing 6xHis-EGFP-Kir6.2ΔC26 in HEK293 cells. Plasmids were propagated in E. coli strain DH5α cultured in 
LB broth or on agar plates with 50 μg/mL ampicillin/kanamycin. Plasmids were purified using plasmid DNA 
isolation kits (Promega) and stored in Tris–EDTA (TE) buffer or Nanopure water at −20 °C. DNA quantity and 
purity was assessed using UV absorbance spectrophotometry  (A260 and  A280), agarose gel electrophoresis, DNA 
sequencing (University of Arizona Genetics Core Facility) and restriction digestion.
For oocytes, the cDNAs of mouse Kir6.2 (GenBank accession number D50581) and hamster SUR1 (Gen-
Bank accession number L40623) were subcloned into pBluescript II SK (Stratagene, La Jolla, CA), creating 
pB.mKir6.2 and pB.SUR1, respectively. Plasmid pB.mKir6.2Δ365–390 was generated by introducing a stop codon 
(R365Stop) into pB.mKir6.2 by site-directed mutagenesis using the QuikChange Mutagenesis kit (Stratagene). 
Capped mRNA was synthesized by in vitro transcription from linearized plasmids employing the mMESSAGE 
mMACHINE kit (Ambion, Austin, TX). The purified mRNA was dissolved in 10 mM Tris–HCl (pH 7.40) and 
stored in aliquots at −80 °C until use.
Transfection of HEK293 cells and selection. Both transient and long-term expressions were initiated 
similarly. Cells were detached using trypsin and resuspended in fresh media at the following approximate densi-
ties: 1.8 ×  104, 1.0 ×  105, 4.2 ×  105, 2.8 ×  106, 1.3 ×  106, and 3.8 ×  106 per well for a 96 well plate, 24 well plate, 35 mm 
petri dish, 100 mm petri dish, 25  cm2 flask, or 75  cm2 flask, respectively. Cell densities were further optimized 
dependent upon cell type and plasmids. Cells were incubated for 24 h or until 80–90% confluency was reached 
for transient expression and 50–60% for long-term expression. At this point, transfection was performed using 
Lipofectamine 2000 (Invitrogen). Lipofectamine:DNA ratios were optimized by monitoring protein expression 
48 h following transfection under varying ratios where an optimized ratio of 2.5 μL Lipofectamine: 1 μg of DNA 
was identified. Lipofectamine:DNA was added to cells in serum free Opti-MEM media, incubated for 4 h, fol-
lowed by replacement with serum-supplemented media. Cells were incubated for 24–48 h to facilitate optimum 
transient protein expression. Long-term expressions were performed using Zeocin selection. Transfected cells 
were split after 48 h into new flasks or dishes, allowed to adhere to the surface for 12–24 h, and media replaced 
with Zeocin-doped media. Initial rounds of selection were typically performed in 24 well plates with a series of 
concentrations ranging from 50 to 500 μg/mL Zeocin. Media were changed every 2–3 days and cells were split 
as necessary. Typically 2–3 splits were performed prior to stable expression.
RT‑PCR. Expression of constructs was further verified via reverse transcriptase-PCR (RT-PCR). RNA was 
isolated from wild-type and transfected (6xHis-Kir6.2, 6xHis-EGFP-Kir6.2ΔC26, and 6xHis-Kir6.2ΔC26) cells 
using SV Total RNA isolation kit (Promega). RT-PCR was performed on isolated RNA using AccessQuick RT-
PCR kit (Promega). Forward and reverse primers for 6xHis-EGFP-Kir6.2ΔC26 and 6xHis-Kir6.2ΔC26 were 
designed: 5′-GCG GCC GCA TGG GGG GTT CTC ATC ATC A-3′ (6xHis-Kir6.2ΔC26 Forward), 5′-TCT 
AGA TCA GGC TGA GGC GAG GGT-3′ (6xHis-EGFP-Kir6.2ΔC26), 5′-GCG GCC GCA TGG GGG GTT 
CTC ATC ATA-3′ (6xHis-Kir6.2ΔC26 Forward), and 5′-TCT AGA TCA GGC TGA GGC GAG GGT-3′ (6xHis-
Kir6.2ΔC26 Reverse). Non-transfected controls utilized each set of primers. All primers were received from 
Integrated DNA Technologies and diluted into sterile water to prepare 100 μM stock concentrations. Working 
solutions of 10 μM were prepared for use in PCR.
Immunocytochemistry. PentaHis-biotin conjugate (Mouse IgG1) (biotinylated anti-6xHis) was pur-
chased from Qiagen (Catalog #34440). Streptavidin-fluorescein (Catalog #S869) and anti-GFP AlexaFluor 
594 conjugates (Rabbit IgG) (Catalog #A21312) were purchased from Invitrogen. All antibodies were used as 
received. Cells were split onto coverslips 24–48 h prior to immunocytochemical staining. Immediately prior to 
staining, cells were washed twice with PBS, then fixed at room temperature using 4% (v/v) formaldehyde in PBS 
for 60 min. Cell fixation and all subsequent treatments were followed by 2–5 rinses with PBS. For permeabilized 
cells, 0.25% (v/v) Triton X-100 in PBS was added to the cells for 5 min following fixation. Non-specific adsorp-
tion was blocked by treatment with 5% FBS in PBS for 60 min. Expression and orientation of 6xHis-EGFP-
Kir6.2ΔC26 were observed via staining with anti-GFP AlexaFluor 594 (2 µg/mL) in PBS for 60 min. Detection of 
6xHis-Kir6.2ΔC26 required primary and secondary stains as follows: fixed cells were incubated with PentaHis-
biotin conjugate in PBS for 60 min (0.2 µg/mL), followed by 1 µg/mL fluorescein-conjugated streptavidin for 
60 min. Images were acquired using a using Nikon Eclipse TE300 inverted epifluorescence microscope with a 
540/25 excitation filter and 620/60 emission filter for AlexaFluor 594 and 480/30 excitation filter and 535/40 
emission filter for EGFP and fluorescein. Images were collected using a Cascade 650 front illuminated CCD 
camera or MicroMAX 512BFT back illuminated CCD camera (Roper Scientific, Tucson, AZ). MetaVue software 
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version 1.0 (Universal Imaging, Downingtown, PA; https:// www. molec ulard evices. com/) was used to capture 
images and Image  J46 was used to analyze all images.
Electrophysiological recordings. Electrophysiological recordings were used to evaluate channel func-
tion and orientation. For HEK293 cells, recordings were collected using a HEKA EPC-8 using Pulse software 
version 7.0 (HEKA Elektronik Dr. Schulze GmbH, Germany; https:// www. heka. com/ about/ about_ main. html# 
smart- ephys). Pipettes were pulled from borosilicate glass and yielded a measured resistance between 4–6 MΩ. 
For whole-cell recordings, the extracellular solution (bath solution) was composed of (in mM): 138 NaCl, 5.6 
KCl, 1.2  MgCl2·6H2O, 2.6  CaCl2, and 5 HEPES (pH 7.40). The intracellular solution (pipet solution) was com-
posed of (in mM): 125 KCl, 1  MgCl2·6H2O, 30 KOH, 10 EGTA, and 5 HEPES (pH 7.15).
For oocytes, inside-out recordings of channel activity were obtained at a holding-potential of −80 mV and 
pipette solution containing (in mM): 140 KCl, 1.2  MgCl2·6H2O, 2.6  CaCl2, 5 HEPES at pH 7.40, and an internal 
(bath) solution consisting of (in mM) 140 KCl, 1  MgCl2·6H2O, 10 EGTA, 5 HEPES at pH 7.15. For outside-out 
recordings, the solutions were reversed. Recordings were made using an Axopatch 200 (Axon Instrument, CA). 
Channel records are displayed according to the convention that upward deflections denote outward currents 
and vice versa. The experiments were carried out at room temperature of 20–22 °C. All solutions were prepared 
in deionized water and filtered through a 0.2 µm pore-size filter prior to use. ATP was added as  Mg2+-salt, and 
all reagents were of analytical grade and obtained from Sigma-Aldrich.
Statistical analysis. For electrophysiological recordings, each group vs. control were compared using the 
Student’s t-test. All data are reported as mean ± SD.
Results and discussion
The regulation of the  KATP channel is complex. In addition to known small molecule modulators like ATP, ADP, 
sulfonylureas, etc.,  KATP channel function is regulated by expression, trafficking, and turnover in the plasma mem-
brane. A key-regulatory element within the channel protein is the ER retention signal, RKR, in the C-terminal 
domain of both Kir6.2 and  SUR137. RKR serves as a point of control to ensure that only appropriately assembled 
channels with the correct stoichiometry and subunit composition traffic to the plasma  membrane37.
Though truncated Kir6.2 mutants are known to form functional, ligand gated  K+ channels, the effects of 
truncation on the orientation of Kir6.2 channels in the plasma membrane in the absence of SURx have not been 
explored. To further investigate the role of the RKR sequence in the regulation of  KATP channels, the orientation 
of Kir6.2 mutants and the resulting functional implications, we utilized a combination of immunocytochemistry 
and electrophysiology of mammalian cells and Xenopus oocytes transfected with Kir6.2 mutants. For these stud-
ies, three constructs were prepared using wild-type Kir6.2 as template. Figure 1 shows a schematic representation 
of the (i) wild type Kir6.2; (ii) a C-terminal truncated Kir6.2, (iii) Kir6.2ΔC26 with an N-terminal hexahistidine 
(6xHis) tag (6xHis-Kir6.2ΔC26), and (iv) N-terminal EGFP-chimera of Kir6.2ΔC26 (6xHis-EGFP-Kir6.2ΔC26). 
These constructs were previously shown to generate an ATP-sensitive  K+ current in oocytes and HEK  cells26,44,47. 
Furthermore, the 6xHis tag allows for utilization of commercial antibodies raised against the tag to detect Kir6.2 
mutants as well as facilitating potential purification of the protein in future  applications47. Constructs were 
expressed in oocytes or HEK293, cells that lack native  KATP channel background expression.
In Xenopus oocytes, addition of high concentrations of ATP revealed a population of  K+ channels with a single 
channel amplitude of −2.3 ± 0.5 pA (Fig. 2A, n = 3), in addition to the population with an expected amplitude of 
−3.8 ± 0.3 pA (n = 3). Due to the inward rectification properties of Kir6.2, it is predicted that inverted channels 
with outward oriented N- and C-termini have a single channel amplitude, corresponding to an inverted rectifica-
tion, of around −2  pA26, in good agreement with the observed second population of channel openings (Fig. 2B). 
In addition, when exposing outside-out patches from oocytes expressing Kir6.2ΔC26 to high concentration of 
extracellular ATP, we observed an inhibitory effect on channel activity (Fig. 2C), that likely results from exposure 
of the intracellular face to the extracellular milieu. It was impossible to determine with certainty if all channels, 
both normally oriented and abnormally inserted, were closed at that zero current level. Hence, there is a risk for 
underestimating the effect of extracellular ATP in these trials. However, when Kir6.2DC26 was co-expressed 
with SUR1, no effect of extracellular ATP is seen (Fig. 2D).
To evaluate the expression and orientation of Kir6.2 subunits, immunocytochemistry was performed on trans-
fected HEK293 cells and non-transfected controls. In wild-type Kir6.2, both the N- and C-termini of the protein 
are found on the cytoplasmic face of the cell  membrane2. Thus, no expression of N- or C- terminal epitopes 
should be observed when antibodies towards these regions are introduced to the exterior of the cell. Extracel-
lular localization of the N-terminal 6xHis tag or EGFP was investigated in non-permeabilized cells, whereas 
total Kir6.2 membrane expression was evaluated in permeabilized cells, which allows access to antigens present 
on both the extracellular and cytoplasmic side of the membrane. Previous immunohistochemistry experiments 
have relied on hemagglutinin (HA) tags inserted into the Kir6.2 protein in the extracellular loop of the protein, 
facilitating detection of surface  expression37. Importantly, these protocols were not extended to explore the pos-
sibility of inverted channels, thus potentially inverted channels were not studied. The protocol employed herein 
facilitates assessment of both protein expression and orientation of the varying constructs as outlined below.
Figure 3 shows typical fluorescence images obtained using HEK293 cells transfected with 6xHis-Kir6.2ΔC26. 
No intrinsic fluorescence at the wavelengths utilized was observed from the 6xHis-Kir6.2ΔC26 chimera, thus 
staining is required for visualization. For this task, biotinylated anti-6xHis was labeled with streptavidin-fluores-
cein conjugate. Expression of 6xHis-Kir6.2ΔC26 was observed in both intact and permeabilized cells, suggesting 
that accessible 6xHis moieties are present on both sides of the plasma membranes. In contrast, examination of 
wild-type, non-transfected HEK293 cells revealed no background membrane staining and thus low non-specific 
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adsorption of reagents, demonstrating the reliability of cytochemical detection of inverted channels (Supporting 
Information, Fig. S1). For all immunocytochemistry, at least 10 successful transfections were analyzed, with at 
least 10 images per successful transfection.
In contrast, expression of 6xHis-EGFP-Kir6.2ΔC26 exhibited a markedly different orientation profile. Figure 4 
shows fluorescence images obtained using HEK293 cells transfected with 6xHis-EGFP-Kir6.2ΔC26. As antici-
pated, EGFP fluorescence was observed in all cells regardless of permeabilization. The orientation of EGFP was 
investigated using anti-EGFP-AlexaFluor 594 conjugate since spectral overlap of EGFP and fluorescein limited 
the use of streptavidin-fluorescein conjugates and streptavidin with red-shifted labels exhibited high non-specific 
staining. Upon staining, clear differences in the distribution of EGFP orientation were observed. No significant 
staining of EGFP was observed in intact cells, whereas AlexaFluor 594 signal was observed in all permeabilized 
cells. Combined, these data suggest that the EGFP moiety, and thus the N-terminus of the Kir6.2 chimera, is 
expressed on the cytoplasmic side of the cell membrane as is found in wild-type  KATP channels, with little or no 


























































Figure 2.  SUR1 affects orientation of Kir6.2 in the membrane. (A) Representative inside-out recording of 
channel currents from an oocyte injected with mRNA encoding Kir6.2ΔC26. Inset shows channel activity at 
an expanded time scale. Two populations of channel openings are observed, −3.8 ± 0.5 pA and −2.2 ± 0.3 pA 
(arrow). (B) Amplitude histogram of inside-out current traces from patches excised from oocytes injected 
with Kir6.2ΔC26 alone (left) or together with SUR1 (right). Data were obtained in the presence of 1 mM ATP 
in the bath solution (i.e. intracellular side). Arrow indicates additional population of channel openings seen 
in the absence of SUR1. A total of 22 ×  103 and 38 ×  103 events were obtained, respectively. (C) Representative 
recordings from Kir6.2ΔC26 channel activity from an outside-out patch, subsequently exposed to 1 mM ATP. 
(D) Summary of outside-out patches from oocytes injected with Kir6.2ΔC26 + SUR1 (n = 3) and Kir6.2ΔC26 
(n = 4), and the effect of extracellularly 1 mM ATP expressed as the ratio between the current measured before 
and during ATP. Arrowhead indicated zero current level, error bars are ± SD and ** represents P < 0.01.
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Figure 3.  Immunocytochemistry of HEK293 cells transfected with 6xHis-Kir6.2ΔC26. Intact (A, B) and 
permeabilized (C, D) cells were utilized to explore the orientation of 6xHis-Kir6.2ΔC26 within the cell 
membrane. Biotinylated anti-6xHis was observed using streptavidin-fluorescein conjugate. Bright-field images 
(B and D) are provided for reference, and all images are on the same intensity scale.
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Figure 4.  Immunocytochemistry of HEK293 cells transfected with 6xHis-EGFP-Kir6.2ΔC26. Intact (A–C) and 
permeabilized (D–F) cells were utilized to explore the orientation of 6xHis-EGFP-Kir6.2ΔC26 within the cell 
membrane. EGFP fluorescence (A and D) was observed under all conditions, whereas fluorescence resulting 
from anti-EGFP-AlexaFluor 594 conjugate was only observed in permeabilized cells (B and E). Bright-field 
images (C and F) are provided for reference. All fluorescent images are on the same intensity scale.
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To correlate the function of Kir6.2ΔC26 subunits outlined above with membrane orientation, electrophysi-
ological characterization of HEK293 cells transfected with either 6xHis-Kir6.2ΔC26 or 6xHis-EGFP-Kir6.2ΔC26 
was performed using whole-cell recordings (Fig. 5). Though whole-cell recordings monitor the net macroscopic 
current for the entire cell, the capability to monitor  K+ flux in the presence and absence of membrane side-specific 
Kir6.2 modulators facilitates investigation of orientation. Non-transfected and transfected HEK293 cells were 
chosen for these experiments as they do not natively express  KATP channels and typically have low total ion cur-
rents prior to transfection. Whole-cell currents were measured when the cells were immersed in extracellular 
solution, followed by exposure to 1 mM ATP on the cytoplasmic side, a concentration sufficient to inhibit >90% 
of  K+ flux via Kir6.2ΔC263,4,26,47. As seen in Fig. 5A, B, exposure to 1 mM ATP reduced the net current by ca. 60% 
in cells transfected with 6xHis-Kir6.2ΔC26. Importantly, the binding site for ATP resides on the cytoplasmic 
side of the wild-type  KATP channel, and ATP does not readily cross the cell membrane. When ATP was removed 
from the solution, whole-cell currents returned to their previous values. Thus, reversible inhibition by ATP is 
supportive of inverted channels within the membrane. In a similar experiment performed on cells transfected 
with 6xHis-EGFP-Kir6.2ΔC26, no statistically significant decrease in  K+ currents were observed. However, larger 
whole-cell currents were observed for cells expressing 6xHis-Kir6.2ΔC26. Thus, the current differences observed 
are likely due to increased protein expression and/or trafficking of 6xHis-Kir6.2ΔC26 compared to the larger 
6xHis-EGFP-Kir6.2ΔC26. Interestingly channel activity was retained even in the presence of physiological  Ca2+ 
levels in the extracellular solution. Wild-type  KATP channels are phosphorylated by intracellular PKA and PKC, 
exposed to adequate cytoplasmic milieu such as low  Ca2+, and associated with phosphatidylinositols, which may 
also lower currents.
To further explore this phenomenon, cells were exposed to thimerosal, a membrane impermeant oxidizing 
agent. Previous studies showed that exposure of the intracellular face of wild-type  KATP channels residing in 
excised membrane patches to thimerosal resulted in loss of channel activity that could be partially reversed 
upon exposure to a suitable reducing agent, e.g.  DTT48. Exposure of cells transfected with 6xHis-Kir6.2ΔC26 to 
thimerosal resulted in a ca. 60% reduction in current, approximately 50% of which was restored upon exposure 
to DTT, in good agreement with previous  work48, at which point whole-cell currents were unchanged upon 
exposure to buffer (Fig. 5). Conversely, no loss of channel activity was observed in cells transfected with 6xHis-
EGFP-Kir6.2ΔC26 upon exposure to thimerosal nor was activity enhanced upon exposure to DTT. When these 
same cells were exposed again to ATP, a ca. 60% decrease in activity was observed for cells expressing 6xHis-
Kir6.2ΔC26. Exposure to inhibiting concentrations of tolbutamide yielded no statistically significant differences 
in whole-cell currents for either construct, an expected result since SUR1 is not expressed in these cells. For 
non-transfected, wild-type HEK293 control cells, sustained low level currents, likely from endogenous ion chan-
nel expression, were observed in all solutions tested with no statistically significant changes upon application of 
 KATP channel modulators (Fig. 5B), supporting the low  KATP background conductance in these cells. HEK293 
cells endogenously express P2Y  receptors49, which could be potentially activated to decrease  KATP channel activ-
ity by reducing  PIP2 near the  KATP  channel39,50. However, since no effect of extracellular applied ATP on  K+ 
current was seen in cells expressing 6xHis-EGFP-Kir6.2ΔC26, the potential effect of P2Y activation is likely 
small. Finally, the current measured for 6xHis-Kir6.2ΔC26 under these conditions is approximately 2 × that for 
6xHis-EGFP-Kir6.2ΔC26. Since the mean channel conductance is similar for both constructs, the observed dif-
ference in current likely results from higher expression and/or membrane trafficking of the significantly smaller 
6xHis-Kir6.2ΔC26.
Though immunocytochemical staining alone might reveal non-functional monomers or oligomers of Kir6.2 
that are inadvertently transported to the plasma membrane, the ligand-modulated  K+ currents that are observed 
upon extracellular addition of ligands strongly support the functional expression of an inverted  K+ channel within 
the cell membrane. Combined, the electrophysiological and immunocytochemical data support the hypothesis 
that Kir6.2ΔC26 transfected into mammalian cells results in a sub-population of inverted ion channels in the 
plasma membrane that retain ligand sensitivity and ion conductance.
In wild-type  KATP channels, the RKR retention signal in both Kir6.2 and SUR1 at the cytoplasmic face provides 
a quality control check that ensures the channels are properly assembled in the ER before further trafficking to 
the Golgi  apparatus36,37. Truncated Kir6.2 mutants that lack the RKR sequence are capable of trafficking to the 
membrane allowing this quality control checkpoint to be bypassed. Our data support the hypothesis that not 
only are Kir6.2 homologous channels able to exit the ER and traffic through the Golgi apparatus to the plasma 
membrane, but that they may form functional channels that are inserted into the plasma membrane in an inverted 
orientation. Interestingly, the attachment of a large, water-soluble protein domain, EGFP in this case, located 
at the N-terminus significantly modulates the orientation of the protein, resulting in normal orientation and 
regulation of the channel within the plasma membrane. We hypothesize that these differences in orientation 
result from changes in post-translation processing of the proteins within the ER. EGFP serves to significantly 
change the orientation of the protein, most likely by introducing a large energetic barrier for protein orientation, 
resulting in unidirectional insertion (Fig. 6).
Lastly, there are many potential binding sites for  PIP2 on Kir6.2, several of which are located in the C-ter-
minus39. The mechanism for how  PIP2 interacts and affects channel activity is not entirely clear, but a possible 
effect with the C-terminal truncation of Kir6.2 is that the channel is activated partly because of its altered  PIP2 
interaction. In that case, it could also explain why truncated Kir6.2 can be open even if abnormally inserted 
into the plasma membrane. A reasonable control would have been full-length Kir6.2. However, this construc-
tion does not generate  K+ conductance without co-expression of SUR1, and hence, co-expression with SUR1 
results in truncated Kir6.2 being normally inserted. Shorter truncations of Kir6.2, like C14 and C18, resulted 
in low  K+  conductance26, so it is likely that the RKR (AA369-371) included in the deletion C26, and no other 
positively charged amino acids in the c-terminal region (Arg-377, Arg-379, and Arg-381) are the main explana-
tion for abnormal insertion. The impact of the His-tag fused to Kir6.2ΔC26 (construct iii, Fig. 1) is difficult to 
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Figure 5.  Whole-cell currents recorded from HEK293-cells expressing of different Kir6.2 variants. (A) 
Current–voltage (I–V) relationships of whole-cell currents in the presence of extracellular solution (denoted 
control), and 1 mM ATP or 10 µM thimerosal, as indicated. The cells were voltage-clamped at 0 mV (holding 
potential  Vh) for 25 ms prior to and following each pulse, and subsequently pulsed in steps of +10 mV for 
150 ms, starting from −100 mV to +150 mV. (B), summary of normalized whole-cell currents of 6xHis-
Kir6.2ΔC26 (open circles), 6xHis-EGFP-Kir6.2ΔC26 (filled circles), and non-transfected HEK293 (filled 
triangles) recorded at 0 mV. Whole-cell currents were normalized using membrane capacitance to compensate 
for variations in cell size. Each recording represents consecutive exposures to control, 1 mM ATP, control, 10 µM 
thimerosal, 1 mM DTT, control, 1 mM ATP, control, and finally 100 µM tolbutamide. Arrowhead indicates zero 
current level, and error bars are ± SD. n = 10 for each cell type. (C) Mean currents were measured from 50 to 
150 ms (dashed lines) and were plotted versus applied potential. Background current measured in transfected 
HEK293 cells was subtracted from mean currents, and plotted under the assumption that EK is −83 mV in the 
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assess, but it appears not to be sufficient to orient the Kir in the normal position as the inclusion of EGFP does 
(construct iv, Fig. 1).
The potential biological significance of these observations is currently unknown. However, mutations in  KATP 
channels that alter trafficking to the plasma membrane have been linked to  PHHI32. It is possible that as yet 
unknown trafficking, assembly and orientation mechanisms may play a role in  KATP channel defects associated 
with abnormal physiological function. The fact that a protein can be translated, trafficked and expressed in a cell 
membrane within a mammalian cell line in an inverted fashion presents a number of intriguing possibilities for 
altered biological function that should be further investigated.
Conclusion
The data presented in this research report is the first observations of inverted ATP-sensitive  K+ channels within 
cellular expression models. Truncated mutants of Kir6.2, when expressed alone, were found to yield randomly 
inserted channel complexes, both normal and abnormal insertions, that were modulated in a cell surface specific 
manner upon application of ligands to the extracellular side of the channel. Abnormal channel population was 
not seen when co-expressed with SUR1. Fusion expression of a large, water-soluble protein domain like EGFP, 
to the cytoplasmic N-terminal domain of the channel resulted in channels that were correctly oriented within 
the cell membrane. We postulate that the lack of the RKR ER retention signal in the truncated Kir6.2 mutants 
used in our experiments prevents proper quality control and that the RKR sequence plays a key role in channel 
orientation in addition to channel assembly during the translation and trafficking processes. While the biological 
significance remains unknown, the existence of abnormally inserted channels presents a number of interesting 
possibilities for defective biological function and warrants further investigation. Further, these data suggest the 
need for caution in interpreting results from cellular studies relying on truncated Kir6.2 mutants and other trun-
cated sequences, as well as potential effects on protein orientation of membrane proteins tagged with fluorescent 
proteins. Finally, expression of inverted channels may present unique opportunities to investigate compounds 
that may modulate Kir6.2 but are membrane impermeant, thus avoiding the need for injection or other delivery 
platforms to study the effects of such compounds.
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